Dacarbazine
Showing 26 - 50 of 280
Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma Trial in Worldwide (AL3818, Dacarbazine, AL3818 or )
Active, not recruiting
- Alveolar Soft Part Sarcoma
- +3 more
- AL3818
- +2 more
-
Phoenix, Arizona
- +22 more
Nov 1, 2022
Soft Tissue Sarcoma Trial in Münster (Dacarbazine, onfekafusp alfa)
Recruiting
- Soft Tissue Sarcoma
- Dacarbazine
- onfekafusp alfa
-
Bordeaux, France
- +15 more
Dec 22, 2022
Classical Hodgkin Lymphoma Trial in Zhengzhou (Camrelizumab, Epirubicin, Vincristine)
Recruiting
- Classical Hodgkin Lymphoma
- Camrelizumab
- +3 more
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Dec 29, 2020
HIV, Hodgkin's Disease Trial in United States (Vinblastine sulfate, Dacarbazine, Filgrastim)
Completed
- HIV Infections
- Hodgkin's Disease
- Vinblastine sulfate
- +4 more
-
Birmingham, Alabama
- +7 more
Oct 26, 2021
Melanoma Trial in Seoul (regorafenib)
Recruiting
- Melanoma
-
Seoul, Korea, Republic ofSeverance Hospital, Yonsei University Health System
Apr 1, 2021
Soft Tissue Sarcoma, Bone Sarcoma Trial in Italy, Spain, United Kingdom (Sunitinib 37.5 MG, Sunitinib 25 MG [Sutent], Nivolumab
Recruiting
- Soft Tissue Sarcoma
- Bone Sarcoma
- Sunitinib 37.5 MG, Sunitinib 25 MG [Sutent]
- +7 more
-
Bologna, Italy
- +12 more
Nov 10, 2021
AIDS-Related Hodgkin Lymphoma, Ann Arbor Stage II Hodgkin Lymphoma, Ann Arbor Stage IIA Hodgkin Lymphoma Trial in France, United
Active, not recruiting
- AIDS-Related Hodgkin Lymphoma
- +11 more
- Brentuximab Vedotin
- +4 more
-
La Jolla, California
- +27 more
Jul 27, 2022
Hodgkin Lymphoma, Adult Trial in Moscow (Doxorubicin, Bleomycin, Vinblastine)
Recruiting
- Hodgkin Lymphoma, Adult
- Doxorubicin
- +7 more
-
Moscow, Russian FederationThe Federal Budget-Funded Institution National Medical Surgical
Nov 20, 2020
Classic Hodgkin Lymphoma Trial (procedure, biological, drug, other, radiation)
Not yet recruiting
- Classic Hodgkin Lymphoma
- Biospecimen Collection
- +19 more
- (no location specified)
Jan 6, 2023
Stage IV Melanoma Trial in Cleveland (recombinant interferon alfa-2b, cisplatin, sodium stibogluconate)
Completed
- Stage IV Melanoma
- recombinant interferon alfa-2b
- +4 more
-
Cleveland, OhioCleveland Clinic Taussig Institute, Case Comprehensive Cancer Ce
Jul 22, 2020
Advanced Hodgkin Lymphoma Trial in Worldwide (Brentuximab Vedotin, Adriamycin, Vinblastine)
Active, not recruiting
- Advanced Hodgkin Lymphoma
- Brentuximab Vedotin
- +6 more
-
Antwerp, Belgium
- +18 more
May 4, 2022
Lymphoma Trial in Southampton (bleomycin sulfate, filgrastim, pegfilgrastim)
Active, not recruiting
- Lymphoma
- bleomycin sulfate
- +10 more
-
Southampton, England, United KingdomSouthampton General Hospital
Apr 27, 2021
Advanced Classical Hodgkin's Lymphoma in Brazil Treated With
Not yet recruiting
- Hodgkin Lymphoma
- No Intervention
-
Salvador, Bahia, Brazil
- +5 more
Oct 23, 2023
Ann Arbor Stage IB Hodgkin Lymphoma, Ann Arbor Stage II Hodgkin Lymphoma, Ann Arbor Stage IIA Hodgkin Lymphoma Trial in United
Active, not recruiting
- Ann Arbor Stage IB Hodgkin Lymphoma
- +10 more
- Brentuximab Vedotin
- Nivolumab
-
Palo Alto, California
- +8 more
Jul 20, 2022
Cutaneous Melanoma Trial in Worldwide (PV-10 (10% rose bengal disodium), Dacarbazine, temozolomide or talimogene laherparepvec)
Terminated
- Cutaneous Melanoma
- PV-10 (10% rose bengal disodium)
- Dacarbazine, temozolomide or talimogene laherparepvec
-
San Diego, California
- +22 more
Jan 17, 2022
Hodgkin Lymphoma Trial in Cologne (ABVD (Adriamycin, Bleomycin, Vincristine, Dacarbazine), 20 Gy IFRT (Involved Field
Unknown status
- Hodgkin Lymphoma
- ABVD (Adriamycin, Bleomycin, Vincristine, Dacarbazine)
- 20 Gy IFRT (Involved Field Radiotherapy)
-
Cologne, Germany1st Dept. of Medicine, Cologne University Hospital
Nov 3, 2020
Hodgkin Lymphoma Trial in Boston (Brentuximab Vedotin, Adriamycin, Dacarbazine)
Completed
- Hodgkin Lymphoma
- Brentuximab Vedotin
- +2 more
-
Boston, Massachusetts
- +1 more
Aug 10, 2020
Ann Arbor Stage I Hodgkin Lymphoma, Ann Arbor Stage I Mixed Cellularity Classic Hodgkin Lymphoma, Ann Arbor Stage I Nodular
Recruiting
- Ann Arbor Stage I Hodgkin Lymphoma
- +13 more
- Bleomycin
- +6 more
-
Birmingham, Alabama
- +16 more
Nov 23, 2021
Progression-free Survival, Overall Survival, Toxicity Trial in Beijing (pegylated liposomal doxorubicin, pirarubicin)
Withdrawn
- Progression-free Survival
- +2 more
- pegylated liposomal doxorubicin
- pirarubicin
-
Beijing, ChinaPeking University People's Hospital
May 15, 2020
Melanoma (Skin) Trial in Beijing (OrienX010 injection, Dacarbazine (DTIC))
Recruiting
- Melanoma (Skin)
- OrienX010 injection
- Dacarbazine (DTIC)
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Feb 25, 2020